Marder E, O'Neil M, Grossman R I, Davis K R, Taveras J M
AJNR Am J Neuroradiol. 1983 Jan-Feb;4(1):61-5.
In a study of the possible mechanisms of the clinical side effects of metrizamide, it was applied to several in vitro model preparations. It was shown that, although high metrizamide concentrations are without noticeable effect on many basic neuronal functions, metrizamide does interfere with cholinergic mechanisms. At concentrations equivalent to, or significantly lower than, those probably achieved during clinical procedures, metrizamide is both an inhibitor of the enzyme acetylcholinesterase and an antagonist of cholinergic transmission. These data suggest the possibility that some of the side effects resulting from clinical procedures employing metrizamide may be explained by its actions on cholinergic synapses.
在一项关于甲泛葡胺临床副作用可能机制的研究中,将其应用于多种体外模型制剂。结果表明,虽然高浓度的甲泛葡胺对许多基本神经元功能没有明显影响,但甲泛葡胺确实会干扰胆碱能机制。在等同于或显著低于临床操作过程中可能达到的浓度下,甲泛葡胺既是乙酰胆碱酯酶的抑制剂,也是胆碱能传递的拮抗剂。这些数据表明,使用甲泛葡胺的临床操作产生的一些副作用可能是由其对胆碱能突触的作用所解释的。